On March 18 and 19, 2021, the National Institute of Allergy and Infectious Diseases (NIAID) is hosting the Accelerating Progress in Celiac Disease Workshop. This two-day, virtual meeting is an important next step in a process catalyzed by the Celiac Disease Foundation’s advocacy efforts in Washington, DC, which gained traction with testimony given by CEO Marilyn Geller to the U.S. House Subcommittee responsible for NIH appropriations in April 2019. As a result of that testimony and the Celiac Disease Foundation’s ongoing work with Members of Congress, report language has been included in both the FY2020 and FY2021 budget directing the NIH to devote “sufficient, focused research to the study of celiac disease”.
We are pleased to share that CEO Marilyn Geller will be presenting as the Patient Advocate. We encourage you to look at the compelling agenda for this seminal workshop where experts in celiac disease and related areas will identify opportunities for research and training of future investigators, and, if possible, register to attend.
A few highlights not to miss include Young Investigator Awardee Dr. Ben Lebwohl, on March 18 at 10:05am EST, discussing “Celiac Disease: The Spectrum of Disease and its Outcomes” followed by CEO Marilyn Geller at 10:30am EST as the Patient Advocate, and Young Investigator Awardee Dr. Valerie Abadie at 2:40pm EST, sharing her research “B cell-mediated immune responses in celiac disease.” On March 19 at 12:30pm EST, Patient Education & Advocacy Summit speakers Drs. Joseph Murray, Daniel Leffler, Patrick Griffin, and Francisco Leon and Young Investigator Awardee Dr. Jocelyn Silvester will discuss current and future diagnostics and therapies.